Brief: Bioxyne Signs Joint Venture With Canxchange

BLS Pharmaceuticals

15/08/2023 02:21

Aug 15 (Reuters) - Bioxyne Ltd  BXN.AX :
    * BIOXYNE SIGNS JOINT VENTURE WITH CANXCHANGE
    * JOINT VENTURE TO LAUNCH AI-POWERED B2B PLATFORM IN
AUSTRALIA
HIGHLIGHTS
    * PLATFORM, EXPECTED TO GO LIVE IN AUSTRALIA IN Q4 2023,
WILL
TARGET AUSTRALIA'S FAST GROWING MEDICINAL CANNABIS

Source text for Eikon:  ID:nASXbDhWwk 
Further company coverage:  BXN.AX 

 ((Reuters.Briefs@thomsonreuters.com;))